rxstat › Classes › Viral Vaccines
Viral Vaccines: shortage status in Canada
1 of the 14 viral vaccines rxstat tracks is currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Twinrix Junior (Hepatitis B Surface Antigen A Virus / Inactivated) Partial shortage 1 of 2 reported products affected
Priorix-Tetra (Mumps Virus Live Attenuated Measles Varicella-zoster Rubella) Shortage anticipated 0 of 1 reported products affected
Haemagglutinin-strain A B (Flulaval Tetra) No current shortage
Hepatitis A Virus / Inactivated (Havrix) No current shortage
Hepatitis B Surface Antigen (Engerix-B) No current shortage
Inactivated Rabies Virus (Rabavert) No current shortage
Influenza Virus Type A B (Flumist Quadrivalent) Discontinued 0 of 1 reported products affected
Poliovirus Type 1 Mahoney 3 Saukett 2 Mef1 (Imovax Polio) No current shortage
Rabies Vaccine Inactivated No current shortage
Gardasil (Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18) Discontinued 0 of 1 reported products affected
Rubella Virus Live Attenuated Measles Mumps (M-M-R Ii) No current shortage
Proquad (Rubella Virus Live Attenuated Mumps Measles Varicella) No current shortage
Varicella-zoster Virus Vaccine Live Attenuated (Zostavax Ii) Discontinued 0 of 1 reported products affected
Yellow Fever Vaccine (Yf-Vax) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.